Suchergebnis | Hamburg Open Science

Facetten

33 Einträge gefunden

The feasibility of prostate cancer detection by triple spectroscopy.
2009 - Forschungsinformationssystem des UKE
Seminal vesicle amyloidosis does not provide any protection from invasion by prostate cancer.
2009 - Forschungsinformationssystem des UKE
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
2008 - Forschungsinformationssystem des UKE
Molecular cancer phenotype in normal prostate tissue.
2008 - Forschungsinformationssystem des UKE
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
2008 - Forschungsinformationssystem des UKE
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
2008 - Forschungsinformationssystem des UKE
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
2008 - Forschungsinformationssystem des UKE
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
2008 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
Nerve distribution along the prostatic capsule.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.
2006 - Forschungsinformationssystem des UKE
Development and internal validation of preoperative transition zone prostate cancer nomogram.
2006 - Forschungsinformationssystem des UKE
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
2006 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

The feasibility of prostate cancer detection by triple spectroscopy.

Seminal vesicle amyloidosis does not provide any protection from invasion by prostate cancer.

Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.

Molecular cancer phenotype in normal prostate tissue.

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.

Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

Nerve distribution along the prostatic capsule.

Development and external validation of an extended 10-core biopsy nomogram.

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.

Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.

Development and internal validation of preoperative transition zone prostate cancer nomogram.

Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.

Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.